Trials / Unknown
UnknownNCT00899327
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
Molecular and Functional Characterisation of Bone Marrow Function in Normal Subjects, Myelodysplastic Syndromes (MDS) and Secondary Disorders of Heamatopoiesis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Oxford University Hospitals NHS Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
RATIONALE: Studying samples of blood and bone marrow in the laboratory from patients at risk of developing myelodysplastic syndrome may help doctors learn more about changes that occur in DNA and identify biomarkers related to disorders of the blood and bone marrow. PURPOSE: This research study is looking at biomarkers in patients at risk of developing myelodysplastic syndrome or other disorders and in healthy participants.
Detailed description
OBJECTIVES: Primary * To identify novel biomarkers of disease that would help in the initial diagnosis of myelodysplastic syndromes (MDS). Secondary * To understand the genesis of anemia in cancers. * To identify novel biomarkers of disease that predict progression of MDS to acute myeloid leukemia. OUTLINE: Blood and bone marrow samples are collected. Hemopoietic stem cells (HSC) and progenitor cells are isolated from samples for analysis. Some of these HSC and progenitor cells are used for functional assays. From the rest of the cells, DNA, RNA, and protein is extracted for molecular analyses, including gene mutation analysis, gene methylation assays, chromatin immunoprecipitation, microarray, and real-time polymerase chain reaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | DNA methylation analysis | |
| GENETIC | RNA analysis | |
| GENETIC | cytogenetic analysis | |
| GENETIC | gene expression analysis | |
| GENETIC | mutation analysis | |
| GENETIC | polymerase chain reaction | |
| GENETIC | protein expression analysis | |
| OTHER | laboratory biomarker analysis |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2011-12-01
- First posted
- 2009-05-12
- Last updated
- 2009-07-08
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00899327. Inclusion in this directory is not an endorsement.